StockData
Allient Inc logo

Allient Inc (ALNT) stock analysis

ALNTNasdaqInstruments For Meas & Testing of Electricity & Elec SignalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3015% above fair value
$84.40−1.88 (-2.18%)

Close on Nov 12, 2026Market cap $1.44BP/E 38.0Yield 0.14%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth2Performance1Health5Dividend2

Mixed10 of 30 checks passed

Allient passes 10 of the 30 checks behind our score; 9 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
2/6
Past performance
1/6
Financial health
5/6
Dividend
2/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 10.1%, above the 10% that usually covers the cost of capital.

  • Interest well covered

    Operating income covers interest expense 5.8 times.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 20.6% of total debt.

  • Low bankruptcy risk

    The Altman Z-score is 5.28; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 14.8% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $86.28 is above our fair value estimate of $75.18.

  • High debt

    Debt is 53.0% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew 3.3% a year over the last three fiscal years, short of the 10% we look for.

Valuation0/6
  • P/E above its 5-year median

    Allient's P/E of 38.9 is above its own 5-year median of 29.4.

  • P/E above the industry

    Allient's P/E of 38.9 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA above its 5-year median

    Allient's EV/EBITDA of 19.2 is above its 5-year median of 13.6.

  • P/B above the industry

    Allient's price-to-book of 4.48 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading above fair value

    The share price of $86.28 is above our fair value estimate of $75.18.

  • Margin of safety under 20%

    The price is 14.8% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 3.3% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew 6.6% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 12.6% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 34.2% over the last twelve months, against 32.6% a year earlier.

Past performance1/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on capital over 10%

    Return on invested capital was 10.1%, above the 10% that usually covers the cost of capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin against the industry

    Needs revenue and net income.

Financial health5/6
  • High debt

    Debt is 53.0% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 83.9% five years ago to 53.0%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 20.6% of total debt.

  • Interest well covered

    Operating income covers interest expense 5.8 times.

  • Short-term assets cover short-term debts

    Current assets are 3.49 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 5.28; above 3 is the safe zone and below 1.8 the distress zone.

Dividend2/6
  • Pays a dividend

    Allient paid dividends worth 0.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Allient yields 0.2%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$75.18

The share price is 15% above this estimate.

20%+ below
Near fair value
20%+ above
$86.28Price$75.18Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E32.9×29.4×36.5×$73.1347%
EV/EBITDA18.6×13.6×23.7×$83.4341%
P/B2.8×2.5×3.2×$54.5212%
Earnings powerleft out, too far from the others11.7% cost of equity––$19.28–
Fair value$75.18100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 29.4
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$21.34M
Value traded per 1% price move
$6.04M

Downside

High risk

Typical loss in a bad month
25.6%
Volatility (annualized)
61%
Sharpe ratio, 1 year
0.97
Beta to the S&P 500 (5Y)
1.37

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

32.8%+3.2 pts over 5 years

Operating margin

7.9%+1.7 pts over 5 years

See a number that looks wrong?